Trials / Completed
CompletedNCT04383678
Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome
Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Multicenter European Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 132 (actual)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate outcomes and predictors of outcome after extracorporeal membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19 patients.
Detailed description
We evaluated the outcome of adult patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) requiring the use of extracorporeal membrane oxygenation (ECMO).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Extracorporeal membrane oxygenation | Veno-venous or veno-arterial extracorporeal oxygenation |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2020-05-12
- Last updated
- 2021-04-20
Locations
11 sites across 6 countries: Finland, France, Germany, Italy, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT04383678. Inclusion in this directory is not an endorsement.